Top of this page
Skip navigation, go straight to the content

Newsroom Press Releases

Search Press releases


UCB First Nine Months Interim Report 2018: UCB tracking well towards full year financial outlook29 Oct 2018

UCB First Nine Months Interim Report 2018: UCB tracking …

Read more
Bimekizumab Showed Sustained Improvements in Both Joint and Skin Outcomes for Psoriatic Arthritis Patients23 Oct 2018

Bimekizumab Showed Sustained Improvements in Both Joint and Skin Outcomes …

Read more
UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus22 Oct 2018

UCB and Biogen Announce Topline Results from a Phase 2b …

Read more
UCB Presents New Long-Term Data Showing Substantial Impact for CIMZIA® (Certolizumab Pegol) in Axial Spondyloarthritis and Rheumatoid Arthritis and Late-Breaking Bimekizumab Data in Psoriatic Arthritis 18 Oct 2018

UCB Presents New Long-Term Data Showing Substantial Impact for …

Read more
UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis into Confirmatory Development Phase18 Oct 2018

UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis into Confirmatory …

Read more
The impact of fragility fractures due to osteoporosis is being ignored18 Oct 2018

The impact of fragility fractures due to osteoporosis is being …

Read more


Stay up-to-date on the latest news and information from UCB